We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

XRCC1 632 as a candidate for cancer predisposition via a complex interaction with genetic variants of base excision repair and double strand break repair genes

    Amrita Singh

    Department of Biotechnology, Thapar University, Patiala, Punjab 147002, India

    ,
    Navneet Singh

    Department of Pulmonary Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Sector 14, Chandigarh, India

    ,
    Digambar Behera

    Department of Pulmonary Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Sector 14, Chandigarh, India

    &
    Siddharth Sharma

    *Author for correspondence:

    E-mail Address: siddharthsharma.phd@thapar.edu

    Department of Biotechnology, Thapar University, Patiala, Punjab 147002, India

    Published Online:https://doi.org/10.2217/fon-2019-0297

    Aim: The DNA repair system safeguards integrity of DNA. Genetic alterations force the improper repair which in conjugation with other factors ultimately results in carcinogenesis. Materials & methods: PCR-restriction fragment length polymorphism was used for genotyping, which was followed by statistical analysis using logistic regression analysis, multifactor dimensionality reduction and classification and regression analysis tree, elaborating the association with lung cancer subjects. Results: Combination of XRCC1 632 and OGG1326 showcased a high risk of eightfold (odds ratio: 7.92; 95% CI: 2.68–23.4; p = 0.0002; false discovery rate (FDR) p = 0.002). Similarly, XRCC1 632 and MUTYH 324 (odds ratio: 5.07; 95% CI: 2.6–9.67; p < 0.0001; FDRp = 0.002) had a high risk. Multifactor dimensionality reduction analysis revealed five factor model as the best model with prediction error of 0.37 (p = 0.02). Conclusion: There was a clear indication that high order interactions were major role players in the study.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Bishop JM. Molecular themes in oncogenesis. Cell 64(2), 235–248 (1991).
    • 2. Levine AJ. The tumor suppressor genes. Ann. Rev. Biochem. 62, 623–651 (1993).
    • 3. Sherr CJ. Cancer cell cycles. Science 274, 1672–1677 (1996).
    • 4. Hartwell LH, Weinert TA. Checkpoints: controls that assure the order of cell cycle events. Science 246, 629–633 (1989).
    • 5. Farber E. The multistep nature of cancer. Cancer Res. 44, 4217–4223 (1984).
    • 6. Fearon ER, Vogelstein BA. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
    • 7. Wei Q, Spitz MR. The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev. 16, 295–307 (1997).
    • 8. de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol. Clin. North Am. 50(5), 863–876 (2012).
    • 9. Wiencke JK, Kelesey KT, Varkonyi A et al. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res. 55, 4910–4914 (1995).
    • 10. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K et al. Molecular mechanism of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39–85 (2004).
    • 11. Jackson PS, Bartek J. The DNA-damage response in human biology and disease. Nature 461, 1071–1078 (2009).
    • 12. Cole BS, Gilbert-Diamond D, Moore JH et al. Analysis of gene–gene interactions. Curr. Protoc. Hum. Genet. 70(1), 1.14.1–1.14.10 (2011).
    • 13. Kim K, Kwon MS, Oh S et al. Identification of multiple gene–gene interactions for ordinal phenotypes. BMCMed. Genomics. 6(Suppl. 2), 6 (2013).
    • 14. Singh A, Singh N, Behera D et al. Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population. DNA Repair 47, 30–41 (2016).
    • 15. Singh A, Singh N, Behera D, Sharma S. Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy. Med. Oncol. 34, 64 (2017).
    • 16. Singh A, Singh N, Behera D et al. Genetic investigation of polymorphic OGG1 and MUTYH genes towards increased susceptibility in lung adenocarcinoma and its impact on overall survival of lung cancer patients treated with platinum based chemotherapy. Pathol.Oncol.Res. 25 (4), 1327–1340 (2015).
    • 17. Singh A, Singh N, Behera D et al. Role of polymorphic XRCC6 (K70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patientsundergoing platinum based doublet chemotherapy. Molecular Biol. Rep. 45 (3), 253–261 (2018).
    • 18. Gangwar R, Ahirwar D, Mandhani A et al. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the north indian population. Mutation Res. 680(1), 56–63 (2006). • Analyzes major genes involved in the study in Indian population.
    • 19. Srivastava A, Srivastava K, Pandey SN et al. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population. Ann. Surg. Oncol. 16(6), 1695–1703 (2009).
    • 20. Szaflik J, Cuchra M, Przybylowska K et al. Association of the 399Arg/Gln XRCC1, the 194 Arg/Trp XRCC1, the 326Ser/Cys OGG1, and the 324 Gln/His Mutyh gene polymorphisms with clinical parameters and the risk for development of primary open angle glaucoma. Mutation. Res. 753(1), 12–22 (2013).
    • 21. Letkova L, Matakova T, Musak L et al. DNA repair gene polymorphism and lung cancer risk with the emphasis to sex differences. Mol. Biol. Rep. 40(9), 5261–5273 (2013).
    • 22. Przybylowska K, Kabzinski J, Sygut A et al. An association selected polymorphisms of XRCC1, OGG1 and mutyh gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer. Mutation Research 745, 6–15 (2013).
    • 23. Qian B, Zhang H, Zhang L et al. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73(2), 138–146 (2011).
    • 24. Huang M, Dinney CP, Lin X et al. High order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 16(1), 84–91 (2007).
    • 25. Zhi Y, Jing Y, Yang L et al. Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk. Int. J. Med. Sci. 9(6), 498 (2012).
    • 26. Michiels S, Laplanche A, Boulet T et al. Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. Carcinogenesis 30(5), 763–768 (2009).
    • 27. Patil MN, Datkhile KD, Bhosale SJ et al. Role of genetic polymorphisms in XRCC4, XRCC5, XRCC6 and XRCC7 in breast cancer susceptibility in rural Indian population: a hospital based case–control study from Maharashtra. Int. J. Health Sci. Res. 6(11), 24–32 (2016). •• The study compared genes for the first time taken up in the present study in Indian population.
    • 28. Datkhile K, Vhaval RD, Patil MN et al. Role of genetic polymorphisms in DNA repair genes (XRCC1, XRCC2, XRCC3, XRCC4, XRCC5, XRCC6, XRCC7) in head and neck cancer susceptibility in rural Indian population: a hospital based case–control study from south-western maharashtra. Int. J. Curr. Res. 8, 25482–25492 (2016).
    • 29. Horikawa Y, Gu J, Wu X. Genetic susceptibility to bladder cancer with an emphasis on gene–gene and gene–environmental interactions. Curr. Opin. Urol. 18(5), 493–498 (2008).
    • 30. Rai R, Kim JJ, Misra S et al. A multiple interaction analysis reveals adrb3 as a potential candidate for gallbladder cancer predisposition via a complex interaction with other candidate gene variations. Int. J. Mol. Sci. 16(12), 28038–28049 (2015).
    • 31. Das S, Bhowmik A, Bhattacharjee A et al. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene–gene and gene–environment interactions. Tumor Biology 36(10), 7569–7579 (2015).
    • 32. Ritchie MD, Hahn HW, Roodi N et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen–metabolism genes in sporadic breast cancer. Am. J. Human Genetics 69(1), 138–147 (2001).
    • 33. Liu L, Wu C, Wang Y et al. Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32(3), 336–342 (2010).
    • 34. Liu L, Wu J, Zhong R et al. Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Mol. Carcinog. 52, 923–931 (2013).
    • 35. Huang M, Dinney CP, Lin X et al. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 16, 84–91 (2007). • Depicts a high order interactions in base excision repair pathway in relation to smoking.